These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 1332213
21. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. Leyvraz PF, Bachmann F, Hoek J, Büller HR, Postel M, Samama M, Vandenbroek MD. BMJ; 1991 Sep 07; 303(6802):543-8. PubMed ID: 1655136 [Abstract] [Full Text] [Related]
22. A double-blind randomized placebo controlled trial of thromboprophylaxis in major elective general surgery using once daily injections of a low molecular weight heparin fragment (Fragmin). Ockelford PA, Patterson J, Johns AS. Thromb Haemost; 1989 Dec 29; 62(4):1046-9. PubMed ID: 2559484 [Abstract] [Full Text] [Related]
23. [Evaluation of the effectiveness and safety of Fragmin (Kabi 2165) versus calcium heparin in the prevention of deep venous thrombosis in general surgery]. Creperio G, Marabini M, Ciocia G, Bergonzi M, Fincato M. Minerva Chir; 1990 Sep 15; 45(17):1101-6. PubMed ID: 2177861 [Abstract] [Full Text] [Related]
24. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations. Bellosta R, Ferrari P, Luzzani L, Carugati C, Cossu L, Talarico M, Sarcina A. Angiology; 2007 Sep 15; 58(3):316-22. PubMed ID: 17626986 [Abstract] [Full Text] [Related]
25. Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. de Valk HW, Banga JD, Wester JW, Brouwer CB, van Hessen MW, Meuwissen OJ, Hart HC, Sixma JJ, Nieuwenhuis HK. Ann Intern Med; 1995 Jul 01; 123(1):1-9. PubMed ID: 7539233 [Abstract] [Full Text] [Related]
28. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Simonneau G, Charbonnier B, Decousus H, Planchon B, Ninet J, Sie P, Silsiguen M, Combe S. Arch Intern Med; 1993 Jul 12; 153(13):1541-6. PubMed ID: 8391792 [Abstract] [Full Text] [Related]
29. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients. Harenberg J, Kallenbach B, Martin U, Dempfle CE, Zimmermann R, Kübler W, Heene DL. Thromb Res; 1990 Aug 01; 59(3):639-50. PubMed ID: 2173168 [Abstract] [Full Text] [Related]
30. Comparison of Once-Daily Bemiparin with Twice-Daily Enoxaparin for Acute Deep Vein Thrombosis: A Multicenter, Open-Label, Randomized Controlled Trial. Suchkov IA, Martinez-Gonzalez J, Schellong SM, Garbade T, Falciani M, Bemiparin DVT Study Group. Clin Drug Investig; 2018 Feb 01; 38(2):181-189. PubMed ID: 29214507 [Abstract] [Full Text] [Related]
31. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators. Harenberg J, Schmidt JA, Koppenhagen K, Tolle A, Huisman MV, Büller HR. Thromb Haemost; 2000 May 01; 83(5):652-6. PubMed ID: 10823256 [Abstract] [Full Text] [Related]
32. Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement. Freick H, Haas S. Thromb Res; 1991 Jul 01; 63(1):133-43. PubMed ID: 1658962 [Abstract] [Full Text] [Related]
33. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke. Sandset PM, Dahl T, Stiris M, Rostad B, Scheel B, Abildgaard U. Semin Thromb Hemost; 1990 Oct 01; 16 Suppl():25-33. PubMed ID: 1962901 [Abstract] [Full Text] [Related]
34. Treatment of established venous thromboembolism with enoxaparin: preliminary report. Huet Y, Janvier G, Bendriss PH, Winnock S, Dugrais G, Freyburger G, Boisseras P. Acta Chir Scand Suppl; 1990 Oct 01; 556():116-20. PubMed ID: 1963016 [Abstract] [Full Text] [Related]
35. Regression of deep vein thrombosis by i.v.-administration of a low molecular weight heparin--results of a pilot study. Kirchmaier CM, Lindhoff-Last E, Rübesam D, Scharrer I, Vigh Z, Mosch G, Wolf H, Breddin HK. Thromb Res; 1994 Mar 01; 73(5):337-48. PubMed ID: 8016818 [Abstract] [Full Text] [Related]
36. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis. Hirsh J. Haemostasis; 1996 Oct 01; 26 Suppl 4():189-98. PubMed ID: 8979124 [Abstract] [Full Text] [Related]
37. Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study. Albada J, Nieuwenhuis HK, Sixma JJ. Circulation; 1989 Oct 01; 80(4):935-40. PubMed ID: 2551537 [Abstract] [Full Text] [Related]
38. A 6-month venographic follow-up in 164 patients with acute deep vein thrombosis. Holmström M, Lindmarker P, Granqvist S, Johnsson H, Lockner D. Thromb Haemost; 1997 Aug 01; 78(2):803-7. PubMed ID: 9268175 [Abstract] [Full Text] [Related]
39. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis. Ramacciotti E, Araújo GR, Lastoria S, Maffei FH, Karaoglan de Moura L, Michaelis W, Sandri JL, Dietrich-Neto F, CLETRAT Investigators. Thromb Res; 2004 Aug 01; 114(3):149-53. PubMed ID: 15342210 [Abstract] [Full Text] [Related]
40. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. Lensing AW, Prins MH, Davidson BL, Hirsh J. Arch Intern Med; 1995 Mar 27; 155(6):601-7. PubMed ID: 7887755 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]